Character Biosciences (Series B)
Funding Details
Awarder
Inbox
Date Award
May 17, 2025
Vertical
Precision Medicine
Funding Amount
$93,000,000
Company Info
Market
Ophthalmology
Location
Jersey City, New Jersey, USA
Coinvestors
aMoon, Luma Group, Bausch + Lomb, Jefferson Life Sciences, Innovation Endeavors, Catalio Capital Management, S32, KdT Ventures
Company Description

Character Biosciences is a precision medicine company developing targeted therapies for progressive polygenic diseases, starting with ophthalmology. By integrating genomics, deep clinical data, and AI-driven modeling, Character Bio identifies disease drivers to improve the success rate of drug development.

Links